نتائج البحث - "romosozumab"

1

Modeling‐Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial

المؤلفون: Stéphane Horlait, Donald Betah, Jacques P. Brown, Cesar Libanati, Yifei Shi, Rogely W. Boyce, Erik Fink Eriksen, Pascale Chavassieux, Roland Chapurlat

المصدر: Journal of Bone and Mineral Research. 37:36-40

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe42f8075c8218191df7e01ef61cc7eTest
https://doi.org/10.1002/jbmr.4457Test

2

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

المؤلفون: Paul D Meisner, Andreas Grauer, Yifei Shi, Michael A. Bolognese, Michael R. McClung, Bente L. Langdahl, Judy Maddox, Jacques P. Brown, Jean-Yves Reginster, Maria Rojeski

المصدر: McClung, M R, Bolognese, M A, Brown, J P, Reginster, J Y, Langdahl, B L, Maddox, J, Shi, Y, Rojeski, M, Meisner, P D & Grauer, A 2020, ' A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab ', Osteoporosis International, vol. 31, no. 11, pp. 2231-2241 . https://doi.org/10.1007/s00198-020-05502-0Test
Osteoporosis International

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Osteoporosis, Urology, Romosozumab, Phases of clinical research, 030209 endocrinology & metabolism, Placebo, Zoledronic Acid, Follow-on regimen, antiresorptive, 03 medical and health sciences, 0302 clinical medicine, Bone Density, Internal medicine, Bone mineral density, medicine, Humans, Osteoporosis, Postmenopausal, Aged, romosozumab, Bone mineral, Bone Density Conservation Agents, business.industry, Antibodies, Monoclonal, Middle Aged, follow-on regimen, medicine.disease, osteoporosis, Rheumatology, Antiresorptive, Regimen, Denosumab, Original Article, Female, 030101 anatomy & morphology, bone mineral density, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6aac61337103cd7cadb5824091c5c7Test
https://doi.org/10.1007/s00198-020-05502-0Test

3

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

المؤلفون: Ki Hyun Baek, Sang Jin Lee, Hyungjin Cho, Sung Kil Lim, Jung Min Koh, Yong Ki Min, Judy Maddox, Wenjing Yang, In Joo Kim, Sooa Kim, Yoon Sok Chung, Rajani Dinavahi, Ki Deok Park, Kyoung Min Kim

المصدر: Endocrinology and Metabolism
Endocrinology and Metabolism, Vol 36, Iss 1, Pp 60-69 (2021)

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Bone density, Endocrinology, Diabetes and Metabolism, Osteoporosis, Romosozumab, Urology, 030209 endocrinology & metabolism, Placebo, lcsh:Diseases of the endocrine glands. Clinical endocrinology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, N-terminal telopeptide, Randomized controlled trial, law, Bone Density, Injection site reaction, Republic of Korea, medicine, Humans, Femoral neck, lcsh:RC648-665, Korea, Bone Density Conservation Agents, business.industry, Antibodies, Monoclonal, medicine.disease, Postmenopause, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Original Article, Female, business, Bone turnover markers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::502d5c29e5945076bf818439640987a8Test
http://europepmc.org/articles/PMC7937846Test

4

Romosozumab: a Review of Efficacy, Safety, and Cardiovascular Risk

المؤلفون: Jennifer A. Tunoa, Cy W. Fixen

المصدر: Current Osteoporosis Reports. 19:15-22

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::386ebb04737a363a8b0fb357e1999b4aTest
https://doi.org/10.1007/s11914-020-00652-wTest

5

Skeletal responses to romosozumab after 12 months of denosumab

المؤلفون: Yifei Shi, Cesar Libanati, Mary Oates, Bente L. Langdahl, Jacques P. Brown, Michael R. McClung, Jean-Yves Reginster, Arkadi Chines, Jen Timoshanko, Michael A. Bolognese

المصدر: McClung, M R, Bolognese, M A, Brown, J P, Reginster, J Y, Langdahl, B L, Shi, Y, Timoshanko, J, Libanati, C, Chines, A & Oates, M K 2021, ' Skeletal responses to romosozumab after 12 months of denosumab ', JBMR Plus, vol. 5, no. 7, e10512 . https://doi.org/10.1002/jbm4.10512Test
JBMR Plus, Vol 5, Iss 7, Pp n/a-n/a (2021)
JBMR Plus